Drug Interactions between amiodarone and Entresto
This report displays the potential drug interactions for the following 2 drugs:
- Entresto (sacubitril/valsartan)
Interactions between your drugs
No interactions were found between amiodarone and Entresto. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Amiodarone is in the drug class group III antiarrhythmics.
- Amiodarone is used to treat the following conditions:
- Entresto is in the drug class angiotensin receptor blockers and neprilysin inhibitors.
- Entresto is used to treat Heart Failure.
Drug and food interactions
Applies to: amiodarone
Amiodarone may be taken with or without food but should be taken at the same way each time. You should avoid consuming grapefruits and grapefruit juice while taking amiodarone. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor. Grapefruit can raise the levels of amiodarone in your body and lead to dangerous side effects. This can affect the rhythm of your heart. Call your doctor if you have symptoms of irregular heartbeat, chest tightness, blurred vision or nausea.
Applies to: Entresto (sacubitril / valsartan)
If you are taking valsartan you should avoid potassium-containing salt substitutes or over-the-counter potassium supplements without first talking to your doctor. This can cause high levels of potassium in your blood. High levels of potassium can cause weakness, irregular heartbeat, confusion, tingling of the extremities, or feelings of heaviness in the legs. Call your doctor at once if you have any of these symptoms.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|